NCT05520411

Brief Summary

Flatter Me is a product that includes digestive enzymes in a way to support digestion of macronutrients and their constituents and provides herbs traditionally used for digestive health support. This trial aims to test Flatter Me against a placebo pill to examine differences in both subjective outcomes (feelings of bloating and indigestion) and changes in waist circumference (abdominal distension) after eating a test meal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 29, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2023

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

7 months

First QC Date

August 26, 2022

Last Update Submit

March 14, 2023

Conditions

Keywords

digestionbloating

Outcome Measures

Primary Outcomes (1)

  • Perceived Changes in Bloating and Stomach Distention

    Questionnaires will be administered to participants at multiple time points before and after eating a test meal. Symptom severity is rated on a scale of 0 (None) to 4 (Extremely Severe)

    1 Week

Secondary Outcomes (1)

  • Visible changes in stomach distension.

    1 week

Study Arms (1)

HUM Flatter Me

EXPERIMENTAL

Come to Citruslabs Office twice (1 Week Gap Between Visits) Visit 1: Take Placebo or Test Product; Eat Test Meal; Outcome Measures Visit 2: Take Placebo or Test Product; Eat Test Meal; Outcome Measures

Dietary Supplement: HUM Flatter Me

Interventions

HUM Flatter MeDIETARY_SUPPLEMENT

Proprietary Enzyme Blend: Protease 3.0 Protease 4.5 Protease 6.0 Neutral Bacterial Protease Peptidase Bromelain Papain Lipase Amylase Glucoamylase Alpha-galactosidase Invertase Diastase Hemicellulase + Cellulase Beta-Glucanase Phytase Lactase Ginger Root Fennel Seed Peppermint Leaf

HUM Flatter Me

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Self Report bloating or stomach distension at least once per day after eating

You may not qualify if:

  • Females who are pregnant or breastfeeding
  • Currently taking any prescribed medication meant to treat gut health
  • Currently taking any medication for fluid balance (i.e., Aldactone)
  • Currently suffers from any pre-existing condition that would prevent them from adhering to the protocol.
  • Currently suffers from any pre-existing condition that would prevent them from consuming cheese pizza.
  • Use of an antibiotic in the previous 3 months.
  • Taking an iron supplement with \> 65mg of iron in the last week.
  • Diagnosed with any of IBS, chronic constipation, GERD, Crohn's Disease, ulcerative colitis, celiac disease, liver disease, kidney disease, heart failure.
  • Lactose Allergy or Intolerance
  • Any food allergies
  • Current smoker
  • Wears dentures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Gastric Dilatation

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Christopher Hill, PhD

    Citruslabs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2022

First Posted

August 29, 2022

Study Start

July 1, 2022

Primary Completion

January 15, 2023

Study Completion

January 15, 2023

Last Updated

March 16, 2023

Record last verified: 2023-03

Locations